• ABL Diagnostics’ main shareholder, Advanced Biological Laboratories, filed an AMF notice for an over-the-counter sale of a new block of shares.
• The shares were sold to a private third party.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein.